These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Local effect of Cytembena and Bucky's rays on superficial basaliomas and Bowen's disease. Trnka J Neoplasma; 1971; 18(5):467-70. PubMed ID: 5119522 [No Abstract] [Full Text] [Related]
4. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma. Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867 [No Abstract] [Full Text] [Related]
5. Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes. Milunicová A; Jandová A; Skoda V Neoplasma; 1971; 18(3):289-98. PubMed ID: 5093948 [No Abstract] [Full Text] [Related]
6. [Therapy of inflammatory rheumatic diseases using cytembena]. Hándlová D; Vojtísek O; Králová M; Brémová A; Kanková D; Pavelka K Fysiatr Revmatol Vestn; 1972 Oct; 50(5):278-83. PubMed ID: 4538713 [No Abstract] [Full Text] [Related]
7. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)]. Matĕjková E; Rezábek K; Polák E Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038 [No Abstract] [Full Text] [Related]
8. [Incidence of bacterial flora in the vagina and urine in patients with gynecologic neoplasms during short-term administration of cytostatics]. Jandovà A; Novotnà J; Skoda V; Trnka V Cesk Gynekol; 1973 Jul; 38(6):420-2. PubMed ID: 4731601 [No Abstract] [Full Text] [Related]
9. [The immunosuppressive effect of Cytembena in rheumatoid arthritis (author's transl)]. Truhlár P; Matl I Cas Lek Cesk; 1975 Jan; 114(5):150-2. PubMed ID: 1120331 [No Abstract] [Full Text] [Related]
10. Cytembena treatment of advanced gynaecological carcinomas. Dvorák O Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520 [No Abstract] [Full Text] [Related]
11. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour. Jandová A; Andrysek O; Macků F; Sámal J; Stránská E Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907 [No Abstract] [Full Text] [Related]
12. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour. Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516 [No Abstract] [Full Text] [Related]
13. Contribution to elucidation of biochemical action mechanism of Cytembena. Slavíková V; Semonský M; Slavík K; Zikán V; Bloch A; Veselá H Neoplasma; 1971; 18(5):455-7. PubMed ID: 5119518 [No Abstract] [Full Text] [Related]
14. A phase II clinical trial of cytembena. Clinical screening group of E.O.R.T.C. Biomedicine; 1977 Dec; 26(6):392-5. PubMed ID: 342004 [TBL] [Abstract][Full Text] [Related]
15. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma. Veselá H; Jelínek V; Pujman V; Zlatkovská Z Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519 [No Abstract] [Full Text] [Related]
16. [Effect of toxic dose of Cytembena on the rat kidney]. Rehulová E; Bartosová M Cesk Patol; 1974 Nov; 10(4):180-3. PubMed ID: 4461154 [No Abstract] [Full Text] [Related]
17. [New Czechoslovak cytostatic preparation Cytembena in the treatment of rheumatoid arthritis (author's transl)]. Truhlár P; Machácek P; Smahel O Cas Lek Cesk; 1973 Nov; 112(45):1401-2. PubMed ID: 4800526 [No Abstract] [Full Text] [Related]
18. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy. Matĕjková E; Vlastiborová A Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661 [No Abstract] [Full Text] [Related]
19. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma. Skoda V; Jandová A; Novotná J Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150 [No Abstract] [Full Text] [Related]
20. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer. Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]